Aren Karapetyan, Radiation Oncologist, Research Fellow at Immune Oncology Research Institute and Content Editor at OncoDaily, shared a post on LinkedIn:
“Our latest research on global public interest in radiotherapy has been accepted for ESTRO 2026. Working at the crossroads of clinical practice as a radiation oncologist and content creator at OncoDaily inspired this project.
We analyzed four years of Google Trends data to understand how the public views radiotherapy modalities and risks.”
More from Aren Karapetyan on OncoDaily.